Analyst Ratings for ADMA Biologics (ADMA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/19/2023 | Raymond James » Updated 8/10/2023 |
Gary Nachman | New Coverage | Strong Buy (N/A) |
6.00 (5.00) |
3.57 (15.39) |
331.09% | Details |
| 10/13/2022 | Mizuho » Updated 5/8/2025 |
Anthony Petrone | New Coverage | Outperform (N/A) |
35.00 (32.00) |
2.49 (15.39) |
518.07% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


